Ventripoint Diagnostics Ltd. (TSXV:VPT)
0.1150
-0.0050 (-4.17%)
Jun 12, 2026, 1:03 PM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 21.97 million as of June 12, 2026. Its market cap has increased by 16.91% in one year.
Market Cap
21.97M
Enterprise Value
24.52M
Revenue
179.93K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 21.97M, an increase of 221.87%. That is a compound annual growth rate of 6.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 21.97M | -6.75% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cannabix Technologies | 70.02M |
| Theralase Technologies | 68.00M |
| Perimeter Medical Imaging AI | 44.50M |
| Cheelcare | 31.22M |
| Conavi Medical | 26.91M |
| VVT Med | 19.21M |
| Aurora Spine | 17.96M |
| MedX Health | 16.40M |